Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M
Silverback Therapeutics plans to raise up to $151.8 million in its initial public offering, the Seattle-based company said Monday in an updated IPO filing.
The biotech firm will aim to sell 6.95 million shares at $17 to $19 per
…
from My reading List https://ift.tt/33whaNl
Comments
Post a Comment